Patents by Inventor Kiyotaka OKUNO

Kiyotaka OKUNO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11793845
    Abstract: No drug has been available for treating a peripheral sensory neuropathy caused as a side effect by a drug, in particular, by an anticancer drug such as oxaliplatin. A composition for ameliorating peripheral sensory neuropathy, which is characterized by including a Lentinus edodes mycelium extract, ameliorates symptoms induced by the drug such as the anticancer drug, including numbness of extremities, a pain in extremities, a reduction in deep tendon reflection, a reduction in muscle force, allodynia, hyperalgesia, impaired finger fine movement, impaired walking, stumbling, falling, impaired flexion (being difficult or impossible to sit on one's heels, sit cross-legged, sit with one's legs out to one side, sit on a chair, or the like), or paralysis of extremities.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: October 24, 2023
    Assignees: KINKI UNIVERSITY, KOBAYASHI PHARMACEUTICAL CO., LTD.
    Inventors: Shozo Nishida, Masanobu Tsubaki, Tomoya Takeda, Kiyotaka Okuno, Satoshi Wachi
  • Publication number: 20210275616
    Abstract: No drug has been available for treating a peripheral sensory neuropathy caused as a side effect by a drug, in particular, by an anticancer drug such as oxaliplatin. A composition for ameliorating peripheral sensory neuropathy, which is characterized by including a Lentinus edodes mycelium extract, ameliorates symptoms induced by the drug such as the anticancer drug, including numbness of extremities, a pain in extremities, a reduction in deep tendon reflection, a reduction in muscle force, allodynia, hyperalgesia, impaired finger fine movement, impaired walking, stumbling, falling, impaired flexion (being difficult or impossible to sit on one's heels, sit cross-legged, sit with one's legs out to one side, sit on a chair, or the like), or paralysis of extremities.
    Type: Application
    Filed: May 24, 2021
    Publication date: September 9, 2021
    Applicants: KINKI UNIVERSITY, KOBAYASHI PHARMACEUTICAL CO., LTD.
    Inventors: Shozo NISHIDA, Masanobu TSUBAKI, Tomoya TAKEDA, Kiyotaka OKUNO, Satoshi WACHI
  • Publication number: 20190381120
    Abstract: No drug has been available for treating a peripheral sensory neuropathy caused as a side effect by a drug, in particular, by an anticancer drug such as oxaliplatin. A composition for ameliorating peripheral sensory neuropathy, which is characterized by including a Lentinus edodes mycelium extract, ameliorates symptoms induced by the drug such as the anticancer drug, including numbness of extremities, a pain in extremities, a reduction in deep tendon reflection, a reduction in muscle force, allodynia, hyperalgesia, impaired finger fine movement, impaired walking, stumbling, falling, impaired flexion (being difficult or impossible to sit on one's heels, sit cross-legged, sit with one's legs out to one side, sit on a chair, or the like), or paralysis of extremities.
    Type: Application
    Filed: December 19, 2017
    Publication date: December 19, 2019
    Applicants: KINKI UNIVERSITY, KOBAYASHI PHARMACEUTICAL CO., LTD.
    Inventors: Shozo NISHIDA, Masanobu TSUBAKI, Tomoya TAKEDA, Kiyotaka OKUNO, Satoshi WACHI